#regencell bioscience

Collection of regencell bioscience news, found 2 news.

Regencell Bioscience’s investigational liquid-formula RGC-COV19TM shows effectiveness through its enrolled patients in eliminating mild to moderate COVID-19 symptoms within the 6-day treatment period

Regencell Bioscience’s investigational liquid-formula RGC-COV19TM shows effectiveness through its enrolled patients in eliminating mild to moderate COVID-19 symptoms within the 6-day treatment period

  • 17th February 2022

Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”) today announced the results ...

Regencell Bioscience Holdings Limited announces pricing of approximately $21.9 million initial public offering

Regencell Bioscience Holdings Limited announces pricing of approximately $21.9 million initial public offering

  • 17th July 2021

Regencell Bioscience Holdings Limited (NASDAQ:RGC) (“Regencell” or the “Company”), an early-stage bioscience ...